Outcomes of Coronary Artery Bypass Grafting in Patients With Previous Mediastinal Radiation.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 26 08 2022
revised: 25 09 2022
accepted: 08 10 2022
pubmed: 11 11 2022
medline: 7 12 2022
entrez: 10 11 2022
Statut: ppublish

Résumé

Studies have shown that patients with radiation therapy-associated coronary artery disease tend to have worse outcomes with percutaneous revascularization. Previous irradiation has been linked with future internal mammary artery graft disease. Studies investigating the outcomes of coronary artery bypass surgery (CABG) among patients with previous radiation are limited. The Nationwide Readmission Database for the years 2016 to 2019 was queried for hospitalizations with CABG and history of mediastinal radiation. Complex samples multivariable logistic and linear regression models were used to determine the association between the history of mediastinal radiation and in-hospital mortality, 90 days all-cause unplanned readmission rates, and acute coronary syndrome readmission rates. A total of 533,702 hospitalizations (2,070 in the irradiation history group and 531,632 in the control group) were included in this analysis. Patients with radiation therapy history were less likely to have traditional coronary artery disease risk factors and more likely to have associated valvular disease. Patients with a history of irradiation had similar in-hospital mortality and 90-day readmission risk at the expense of higher hospitalizations costs (β coefficient: $2,764; p = 0.005). They had a higher likelihood of readmission with acute coronary syndrome within 90 days (adjusted odds ratio 1.67, p = 0.02). In a conclusion, a history of mediastinal irradiation is not associated with increased rates of short-term mortality or increased all-cause readmission risk after CABG. However, it may be associated with increased acute coronary syndrome readmission rates.

Identifiants

pubmed: 36356429
pii: S0002-9149(22)01112-2
doi: 10.1016/j.amjcard.2022.10.020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-86

Informations de copyright

Published by Elsevier Inc.

Auteurs

Ahmed M Elzanaty (AM)

Division of Cardiovascular Medicine and Department of Internal Medicine, University of Toledo, Toledo, Ohio. Electronic address: Ahmed.elzanaty@utoledo.edu.

Mahmoud Khalil (M)

Department of Internal Medicine, Lincoln Medical Center, New York, New York.

Chandramohan Meenakshisundaram (C)

Division of Cardiovascular Medicine and Department of Internal Medicine, University of Toledo, Toledo, Ohio.

Abdulmajeed Alharbi (A)

Department of Internal Medicine, University of Toledo, Toledo, Ohio.

Neha Patel (N)

Department of Internal Medicine, University of Toledo, Toledo, Ohio.

Ahmed Maraey (A)

Department of Internal Medicine, University of North Dakota, Bismarck, North Dakota.

Fnu Zafarullah (F)

Division of Cardiovascular Medicine and Department of Internal Medicine, University of Toledo, Toledo, Ohio.

Islam Y Elgendy (IY)

Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, Kentucky.

Ehab Eltahawy (E)

Division of Cardiovascular Medicine and Department of Internal Medicine, University of Toledo, Toledo, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH